Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
  • Article usage
  • Citations to this article

Advertisement

Research Article Free access | 10.1172/JCI1146

Substrate availability limits human skeletal muscle oxidative ATP regeneration at the onset of ischemic exercise.

J A Timmons, T Gustafsson, C J Sundberg, E Jansson, E Hultman, L Kaijser, J Chwalbinska-Moneta, D Constantin-Teodosiu, I A Macdonald, and P L Greenhaff

Department of Physiology and Pharmacology, University Medical School, Queen's Medical Centre, Nottingham, United Kingdom. James_Timmons@sandwich.pfizer.com

Find articles by Timmons, J. in: PubMed | Google Scholar

Department of Physiology and Pharmacology, University Medical School, Queen's Medical Centre, Nottingham, United Kingdom. James_Timmons@sandwich.pfizer.com

Find articles by Gustafsson, T. in: PubMed | Google Scholar

Department of Physiology and Pharmacology, University Medical School, Queen's Medical Centre, Nottingham, United Kingdom. James_Timmons@sandwich.pfizer.com

Find articles by Sundberg, C. in: PubMed | Google Scholar

Department of Physiology and Pharmacology, University Medical School, Queen's Medical Centre, Nottingham, United Kingdom. James_Timmons@sandwich.pfizer.com

Find articles by Jansson, E. in: PubMed | Google Scholar

Department of Physiology and Pharmacology, University Medical School, Queen's Medical Centre, Nottingham, United Kingdom. James_Timmons@sandwich.pfizer.com

Find articles by Hultman, E. in: PubMed | Google Scholar

Department of Physiology and Pharmacology, University Medical School, Queen's Medical Centre, Nottingham, United Kingdom. James_Timmons@sandwich.pfizer.com

Find articles by Kaijser, L. in: PubMed | Google Scholar

Department of Physiology and Pharmacology, University Medical School, Queen's Medical Centre, Nottingham, United Kingdom. James_Timmons@sandwich.pfizer.com

Find articles by Chwalbinska-Moneta, J. in: PubMed | Google Scholar

Department of Physiology and Pharmacology, University Medical School, Queen's Medical Centre, Nottingham, United Kingdom. James_Timmons@sandwich.pfizer.com

Find articles by Constantin-Teodosiu, D. in: PubMed | Google Scholar

Department of Physiology and Pharmacology, University Medical School, Queen's Medical Centre, Nottingham, United Kingdom. James_Timmons@sandwich.pfizer.com

Find articles by Macdonald, I. in: PubMed | Google Scholar

Department of Physiology and Pharmacology, University Medical School, Queen's Medical Centre, Nottingham, United Kingdom. James_Timmons@sandwich.pfizer.com

Find articles by Greenhaff, P. in: PubMed | Google Scholar

Published January 1, 1998 - More info

Published in Volume 101, Issue 1 on January 1, 1998
J Clin Invest. 1998;101(1):79–85. https://doi.org/10.1172/JCI1146.
© 1998 The American Society for Clinical Investigation
Published January 1, 1998 - Version history
View PDF
Abstract

We have demonstrated previously that dichloroacetate can attenuate skeletal muscle fatigue by up to 35% in a canine model of peripheral ischemia (Timmons, J.A., S.M. Poucher, D. Constantin-Teodosiu, V. Worrall, I.A. Macdonald, and P.L. Greenhaff. 1996. J. Clin. Invest. 97:879-883). This was thought to be a consequence of dichloroacetate increasing acetyl group availability early during contraction. In this study we characterized the metabolic effects of dichloroacetate in a human model of peripheral muscle ischemia. On two separate occasions (control-saline or dichloroacetate infusion), nine subjects performed 8 min of single-leg knee extension exercise at an intensity aimed at achieving volitional exhaustion in approximately 8 min. During exercise each subject's lower limbs were exposed to 50 mmHg of positive pressure, which reduces blood flow by approximately 20%. Dichloroacetate increased resting muscle pyruvate dehydrogenase complex activation status by threefold and elevated acetylcarnitine concentration by fivefold. After 3 min of exercise, phosphocreatine degradation and lactate accumulation were both reduced by approximately 50% after dichloroacetate pretreatment, when compared with control conditions. However, after 8 min of exercise no differences existed between treatments. Therefore, it would appear that dichloroacetate can delay the accumulation of metabolites which lead to the development of skeletal muscle fatigue during ischemia but does not alter the metabolic profile when a maximal effort is approached.

Version history
  • Version 1 (January 1, 1998): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts